Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
Abstract Background Headache is the dominant factor for quality of life related disability in idiopathic intracranial hypertension (IIH) and typically has migraine-like characteristics.There are currently no evidence-based therapeutics for headache in custom congratulations banner IIH, and consequently this is an important unmet clinical need.Case